glp-1 good or bad Agonist: The Good, the and the Ugly GLP-1 Weight Loss Medications: The

Evidence is limited, but precaution is warranted for individuals on multiple medications

As an example, Zepbound (tirzepatide), is approved by the FDA for chronic weight management in adults with obesity (BMI of 30 kg/m2 or greater) or overweight (BMI of 27 kg/m2 or greater) with at least one weight-related condition, which can include conditions other than type 2 diabetes

Similar to Wegovy, Ozempic requires a once-weekly injection, providing a consistent dose of the medication for improved blood sugar control and appetite regulation

reductions vs GLP-1 RAs ranged from 1.68 kg with tirzepatide 5 mg to 7.16 kg with tirzepatide 15 mg

Zeng J, Chen YZ, Ding R, et al